Pomegranate Extract Ellagic Acid Original Factory

Pomegranate Extract (Ellagic Acid) Direct from Manufacturer is a high-purity natural polyphenolic active ingredient extracted from pomegranate peel and pulp. As a direct manufacturer, we supply professional-grade raw materials to buyers in the plant extract industry, product R&D teams, manufacturing plants, and brand decision-makers. Our offerings feature high purity (HPLC 40%-98%), batch consistency, quality control, and traceable supply chains.

Our products guarantee not only high purity but also compliance with ISO certification standards, offering end-to-end solutions from small-batch samples to long-term tonnage supply. For B2B buyers, selecting our products ensures consistent batch-to-batch uniformity, sustained supply capacity, assurance of international logistics, and comprehensive compliance documentation. This mitigates cross-border procurement risks while safeguarding downstream formulation stability.

Pomegranate extract Ellagic Acid is widely recognised in the market for its antioxidant, anti-inflammatory, and phytopolyphenolic health properties. Research indicates that high concentrations of Ellagic Acid effectively neutralise free radicals, supporting health management. Consequently, this product is suitable not only for raw material distributors but also for enterprises developing proprietary functional products.

PS: This page focuses on the Integrated Supply Chain & Solutions.

For the product application information, please click Antioxidant Ingredient Pomegranate Extract Ellagic Acid.

For the product Technical Data Sheet, please click Pomegranate Extract Ellagic Acid HPLC98% 476-66-4.

As a high-value monomer component extracted from pomegranate peel, ellagic acid faces several critical industrial-scale conversion bottlenecks in its transition from laboratory research to large-scale commercial application. Deeply understanding and resolving these bottlenecks is fundamental to distinguishing between "ordinary extract raw materials" and "high-purity commercial application monomers" – and represents the core value we deliver as a source manufacturer.

Challenge One: The Deep-Seated Conflict Between Solubility Characteristics and Formulation Compatibility

Ellagic acid's molecular structure dictates its distinctive solubility behaviour: slightly soluble in water and alcohols, soluble in alkalis and pyridine, yet insoluble in ethers. This property presents two critical formulation development challenges:

• Dispersion Challenges in Aqueous Systems: Direct incorporation of ellagic acid into water-based products such as functional beverages, oral solutions, and serums may result in uneven dispersion, precipitation, or reduced bioavailability. Simply increasing dosage fails to resolve solubility issues and risks compromising sensory quality.
• pH-dependent solubility behaviour: Ellagic acid exhibits better solubility under alkaline conditions but faces dissolution limitations in acidic to neutral aqueous systems. This necessitates particular attention to its dissolution state and bioavailability under physiological conditions prevalent in most skincare products (pH 4.5–6.5) and oral formulations (pH 2–7).

For B2B clients, this implies: Ellagic acid's "high potency" and "low solubility" are two sides of the same coin. When selecting raw materials, both solubility characteristics and delivery strategies must be considered, not merely purity figures. Clients lacking formulation expertise may encounter risks of unstable dissolution and diminished efficacy during product development.

Our scientific response and product solutions:

1. Multi-specification system support: We offer products ranging from 40% to 98% concentration to meet diverse application requirements. Our water-soluble ellagic acid formulation at 40% concentration is suitable for conventional dietary supplements and skincare formulations. In comparison, the 98% high-purity specification is suitable for functional products and pharmaceutical-grade applications.
2. Solubility Application Data: Drawing on our application laboratory's accumulated expertise, we provide clients with solubility curves and stability data for ellagic acid across diverse pH buffers and solvent systems, supporting formulation engineers in the initial design stages.
3. Delivery Technology Consultancy: For applications requiring stringent solubility, we recommend enhancement solutions, including micronisation, cyclodextrin inclusion complexes, and liposomal encapsulation, and we also support clients in conducting pilot-scale validation trials.

Challenge Two: In Vivo Validation and Claim Support for Multi-Target Efficacy

Extensive literature has confirmed the diverse physiological activities of ellagic acid:

1. Anti-cancer effects: Inhibits multiple cancer cells, including colon, oesophageal, liver, lung, tongue and skin tumours; blocks human papillomavirus DNA replication; and suppresses G1 phase mitosis in cancer cells.
2. Antioxidant and Skin-Lightening Effects: Enhances antioxidant enzyme activity, inhibits tyrosinase, and exhibits skin-lightening properties, protection against UV damage, anti-inflammatory effects, and wound-healing promotion.
3. Cardiovascular Protection: Exhibits blood pressure-lowering and sedative effects.
4. Immune Modulation: Enhances human immune function.

However, a common misconception in industrial translation equates "in vitro activity data" directly with "in vivo effective dosage". Multiple factors, including formulation design, coexisting matrices, and metabolic pathways, influence ellagic acid's bioavailability.

For B2B clients, this implies: validating ellagic acid's efficacy requires traversing the entire chain from "raw material composition spectrum – delivery system – in vivo metabolism – target action". A successfully commercialised ellagic acid project necessitates systematic R&D support underpinned by stable raw materials.

Our scientific response and product solutions:

• Batch Consistency and Traceability: We guarantee high inter-batch consistency in the raw material's composition profile, impurity profile, and key activity indicators. This forms the basis for any subsequent in vivo or in vitro efficacy studies, enabling reproducible data.
• Supporting Efficacy Validation and Claims: Our analytical certificates include detailed testing data, providing reliable raw material assurance for clients conducting in vivo efficacy validation experiments. We can supply foundational research literature on raw materials upon request to support clients' scientific claims.
• Bulk Supply Capacity as a Commercialisation Guarantee: Any exceptional formulation validated through an extended R&D cycle must be underpinned by the long-term, stable, and scalable supply of raw materials. Our factory-direct supply model ensures a seamless transition from successful R&D to mass production and market launch.

We have established a specialised supply chain collaboration process for long-term, bulk, and multinational B2B partnerships, ensuring clients transition smoothly from initial engagement to sustained tonnage procurement.

1. Requirement Discussion: Clients provide formulation specifications, target applications, and projected purchase volumes. We confirm the ellagic acid content, total polyphenol metrics, and impurity limits in accordance with these specifications, whilst discussing packaging and transportation requirements.
2. Sample Validation: We provide small-batch samples for third-party or in-house testing to verify active ingredient content, colour, solubility, and stability.
3. Capacity Assessment and Supply Planning: Based on the customer's annual procurement plan, we pre-schedule production lines and raw material procurement to mitigate seasonal fluctuations in raw material availability. Multi-batch production plans are established to maintain a continuous delivery capability.
4. Contract Signing and Long-Term Collaboration: Customers may enter into annual or multi-year procurement contracts. We provide bespoke packaging, logistics arrangements, and delivery cycle planning to ensure supply chain transparency and control.
5. Batch Production and Delivery: Each production batch undergoes stringent quality control, with a Certificate of Analysis (COA) provided. Packaging and logistics comply with international shipping standards, ensuring consistent product quality from the factory to the customer.

This integrated process enables clients to manage long-term, high-volume, cross-border procurement projects through a single point of contact, while minimising supply disruption and quality risks.

The long-term bulk supply capacity of pomegranate extract ellagic acid relies on scientific production capacity planning and raw material reserve strategies.

• Raw Material Reserves: Pomegranates are harvested seasonally, necessitating concentrated annual procurement of raw materials followed by cold storage or drying. This ensures year-round production remains unaffected by raw material fluctuations.
• Multi-batch Production Strategy: Even tonnage-level orders are fulfilled through batch production, with rigorous testing for each batch to ensure supply stability and consistency.
• Annual Procurement Volume Planning: Supports orders ranging from 100kg trial batches to annual tonnage-level supply commitments, with multi-tonnage continuous supply achievable for select major brands or distributors.
• Safety Stock Mechanism: We maintain optimal inventory levels to guarantee on-time delivery despite transport delays or sudden demand surges. Through scientific capacity planning and multi-batch production arrangements, we undertake long-term bulk and multinational supply projects to meet sustained international market demand.

Core Factory Advantages

1. Source-to-Product Control: With over a decade of specialisation in plant extract R&D and production, we operate an integrated facility spanning raw material sourcing through modern extraction and purification. Our monthly gallic acid production capacity exceeds 1,000 kilograms, accommodating diverse client requirements from small-batch R&D to large-scale commercial manufacturing.
2. Comprehensive International Certifications: Our production facilities adhere to ISO 9001 Quality Management Systems and HACCP Food Safety Management Systems, with critical processes compliant with cGMP guidelines. We also hold international certifications, including KOSHER, HALAL, and ORGANIC, fulfilling specific requirements across diverse markets and religious cultures.
3. Exceptional Purity and Batch Consistency: Utilising proprietary pomegranate-based preparation techniques, ellagic acid core specifications remain stable and controllable.

Cross-border raw material procurement demands high standards of logistical stability and document compliance. Our logistics system is specifically designed for the bulk supply of Pomegranate Extract Ellagic Acid:

• Trade Terms: Supports international trade models, including FOB, CIF, CFR, DAP, DDP, and others, to meet diverse procurement requirements.
• Transportation Methods: Primarily sea freight for tonnage-level orders; air freight for samples or urgent orders; flexible sea-air multimodal solutions for special requirements.
• Logistics Services: Established stable partnerships with international logistics giants, including DHL, FEDEX, UPS, and TNT, providing door-to-door delivery services.

• Estimated Delivery Times:

Sample Orders: 3-5 working days

Small-batch Spot Orders (<100kg): 3-7 days

Bulk air freight orders: 5–8 days

Bulk sea freight orders: 15–30 days (depending on destination)

• Delivery and Ongoing Support: Complete customs documentation (commercial invoice, packing list, certificate of origin, COA, MSDS, etc.) provided with the shipment, along with full logistics tracking, post-delivery monitoring of customer usage with necessary technical consultation.
• Logistics Risk Management: Mitigate port congestion, transport delays and cross-border customs issues whilst offering transport insurance and cargo tracking services.

This logistics framework ensures products are delivered directly from the manufacturer to global customers, maintaining a secure, stable and efficient supply chain.

To ensure product stability during international transit and extended storage, we have devised an industrial-grade packaging solution:

• Inner Packaging: Food-grade aluminium foil pouches or PE-lined bags that protect against moisture, oxidation, and light exposure.
• Outer Packaging: Paper fibre drums or cartons, offering crush resistance and transport durability, suitable for pallet and container loading. Packaging Specifications:

1kg/bag: Aluminium foil pouch (lined with food-grade sterile bag, vacuum-sealed)

25kg/drum: Cardboard drum, lined with a double-layer food-grade plastic bag

Custom packaging available upon request (e.g., 5kg, 10kg)

Tailored packaging or palletised transport solutions are provided for long-term clients.

• Transportation Adaptability: Packaging tested for sea freight, air freight and extended storage, ensuring product activity remains unaffected.

Rational packaging design not only safeguards product quality but also enhances logistics efficiency and storage management convenience, forming a vital component of industrial-grade raw material supply systems.

Ellagic acid stands as one of the core high-purity monomers within our pomegranate extract product line. To support your development of more innovative and competitive end products, we recommend concurrently considering the following products exhibiting synergistic effects or homologous properties:

Visit our official website(www.appchem.cn) for further information and access our complete botanical extract product catalogue for further specialised ingredient solutions.